NewBiologix raised €46M in a Series A round in May 2023. The company is based in Lausanne, Switzerland. Investors in the round: Igor Fish, Nicolas Mermod, Recipharm . Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
